NTRK1 and neoplasm: Due to the presence of multiple driver gene alterations, and the unavailability of NTRK1 inhibitor, the patient then received mediastinal tumor palliative radiotherapy (DT = 18Gy/9F), but responded poorly to the treatment and deceased 16 weeks post-operation (Fig. 1b).